For in vitro diagnostic use. Others Elecsys sFlt-1 IVD Elecsys® sFlt-1 CPS_000512 05109523190 sFLT1 Elecsys cobas e 100 Elecsys sFlt-1 04015630924271 Reagents, kits 100 tests cobas e 411/601/602 true 07027818190 sFLT1 Elecsys E2G 100 Elecsys sFlt-1 04015630940509 Reagents, kits 100 tests cobas e 402/801 true 05109523500 Elecsys sFlt-1 en 11 FF0000000483ED0E FF000000004C570E 05109523190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of soluble fms‑like tyrosine kinase‑1 (sFlt‑1) in human serum.The Elecsys sFlt‑1 assay is used in combination with the Elecsys PlGF assay to determine the sFlt‑1/PlGF ratio. The sFlt‑1/PlGF ratio is intended for use as an aid in the diagnosis of preeclampsia in conjunction with other diagnostic and clinical information.In addition the sFlt‑1/PlGF ratio is intended for use as an aid in short-term prediction of preeclampsia (rule-out and rule-in) in pregnant women with suspicion of preeclampsia in conjunction with other diagnostic and clinical information.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07027818500 Elecsys sFlt-1 en 6 FF000000050D4D0E FF00000004EE980E 07027818190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of soluble fms‑like tyrosine kinase‑1 (sFlt‑1) in human serum.The Elecsys sFlt‑1 assay is used in combination with the Elecsys PlGF assay to determine the sFlt‑1/PlGF ratio. The sFlt‑1/PlGF ratio is intended for use as an aid in the diagnosis of preeclampsia in conjunction with other diagnostic and clinical information.In addition the sFlt‑1/PlGF ratio is intended for use as an aid in short-term prediction of preeclampsia (rule-out and rule-in) in pregnant women with suspicion of preeclampsia in conjunction with other diagnostic and clinical information.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en